{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:02:35Z","timestamp":1793145755886,"version":"4.5.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2021,6,17]],"date-time":"2021-06-17T00:00:00Z","timestamp":1623888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,17]],"date-time":"2021-06-17T00:00:00Z","timestamp":1623888000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Fail Rev"],"published-print":{"date-parts":[[2021,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Peripartum cardiomyopathy is a form of idiopathic systolic heart failure which occurs during the end of pregnancy or the early post-partum in the absence of an identifiable etiology. The exact pathogenesis remains unknown, and the incidence is higher in African ancestry, multiparous and hypertensive women, or older maternal age. Delay in diagnosis is common, mainly because symptoms of heart failure mimic those of normal pregnancy. Echocardiography showing decreased myocardial function is at the center of the diagnosis. Management relies on the general guidelines of management of other forms of non-ischemic cardiomyopathy; however, special attention should be paid when choosing medications to ensure fetal safety. Outcomes can be variable and can range from complete recovery to persistent heart failure requiring transplant or even death. High rates of relapse with subsequent pregnancies can occur, especially with incomplete myocardial recovery. Additional research about the etiology, experimental drugs, prognosis, and duration of treatment after recovery are needed.<\/jats:p>","DOI":"10.1007\/s10741-020-10061-x","type":"journal-article","created":{"date-parts":[[2021,6,17]],"date-time":"2021-06-17T12:02:31Z","timestamp":1623931351000},"page":"1287-1296","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Peripartum cardiomyopathy: a review"],"prefix":"10.1007","volume":"26","author":[{"given":"Corina","family":"Iorgoveanu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Zaghloul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahi","family":"Ashwath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,17]]},"reference":[{"issue":"181","key":"10061_CR1","first-page":"325","volume":"72","author":"C Ritchie","year":"1849","unstructured":"Ritchie C (1849) Clinical contributions to the pathology, diagnosis, and treatment of certain chronic diseases of the heart. Edinb Med Surg J 72(181):325\u2013339","journal-title":"Edinb Med Surg J"},{"key":"10061_CR2","first-page":"550","volume":"89","author":"EHF Hull","year":"1937","unstructured":"Hull EHF (1937) Toxic postpartum heart disease. New Orleans Med Surg J 89:550\u2013557","journal-title":"New Orleans Med Surg J"},{"issue":"7","key":"10061_CR3","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1002\/ejhf.1493","volume":"21","author":"J Bauersachs","year":"2019","unstructured":"Bauersachs J, K\u00f6nig T, van der Meer P et al (2019) Pathophysiology, diagnosis and management of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy. Eur J Heart Fail 21(7):827\u2013843","journal-title":"Eur J Heart Fail"},{"issue":"8","key":"10061_CR4","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1093\/eurjhf\/hfq120","volume":"12","author":"K Sliwa","year":"2010","unstructured":"Sliwa K, Hilfiker-Kleiner D, Petrie MC et al (2010) Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy. Eur J Heart Fail 12(8):767\u2013778","journal-title":"Eur J Heart Fail"},{"issue":"3","key":"10061_CR5","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.tcm.2018.07.012","volume":"29","author":"K Stergiopoulos","year":"2019","unstructured":"Stergiopoulos K, Lima FV (2019) Peripartum cardiomyopathy-diagnosis, management, and long term implications. Trends Cardiovasc Med 29(3):164\u2013173","journal-title":"Trends Cardiovasc Med"},{"issue":"11","key":"10061_CR6","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1001\/jamacardio.2017.3574","volume":"2","author":"OC Irizarry","year":"2017","unstructured":"Irizarry OC, Levine LD, Lewey J et al (2017) Comparison of clinical characteristics and outcomes of peripartum cardiomyopathy between African American and non-African American Women. JAMA Cardiol 2(11):1256\u20131260","journal-title":"JAMA Cardiol"},{"issue":"1","key":"10061_CR7","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1097\/AOG.0b013e3181c4ee8c","volume":"115","author":"EV Kuklina","year":"2010","unstructured":"Kuklina EV, Callaghan WM (2010) Cardiomyopathy and other myocardial disorders among hospitalizations for pregnancy in the United States: 2004\u20132006. Obstet Gynecol 115(1):93\u2013100","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10061_CR8","doi-asserted-by":"publisher","first-page":"e001056","DOI":"10.1161\/JAHA.114.001056","volume":"3","author":"D Kolte","year":"2014","unstructured":"Kolte D, Khera S, Aronow WS et al (2014) Temporal trends in incidence and outcomes of peripartum cardiomyopathy in the United States: a nationwide population-based study. J Am Heart Assoc 3(3):e001056","journal-title":"J Am Heart Assoc"},{"issue":"9","key":"10061_CR9","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1001\/jama.283.9.1183","volume":"283","author":"GD Pearson","year":"2000","unstructured":"Pearson GD, Veille JC, Rahimtoola S et al (2000) Peripartum cardiomyopathy: National Heart, Lung, and Blood Institute and Office of Rare Diseases (National Institutes of Health) workshop recommendations and review. JAMA 283(9):1183\u20131188","journal-title":"JAMA"},{"issue":"1","key":"10061_CR10","first-page":"8","volume":"39","author":"A Bhattacharyya","year":"2012","unstructured":"Bhattacharyya A, Basra SS, Sen P, Kar B (2012) Peripartum cardiomyopathy: a review. Tex Heart Inst J 39(1):8\u201316","journal-title":"Tex Heart Inst J"},{"issue":"20","key":"10061_CR11","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.1161\/CIRCULATIONAHA.110.956169","volume":"121","author":"JL Anderson","year":"2010","unstructured":"Anderson JL, Horne BD (2010) Birthing the genetics of peripartum cardiomyopathy. Circulation 121(20):2157\u20132159","journal-title":"Circulation"},{"issue":"3","key":"10061_CR12","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1093\/cvr\/cvz252","volume":"116","author":"M Ricke-Hoch","year":"2020","unstructured":"Ricke-Hoch M, Pfeffer TJ, Hilfiker-Kleiner D (2020) Peripartum cardiomyopathy: basic mechanisms and hope for new therapies. Cardiovasc Res 116(3):520\u2013531","journal-title":"Cardiovasc Res"},{"issue":"9","key":"10061_CR13","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1161\/hc3401.095947","volume":"104","author":"S Negoro","year":"2001","unstructured":"Negoro S, Kunisada K, Fujio Y et al (2001) Activation of signal transducer and activator of transcription 3 protects cardiomyocytes from hypoxia\/reoxygenation-induced oxidative stress through the upregulation of manganese superoxide dismutase. Circulation 104(9):979\u2013981","journal-title":"Circulation"},{"issue":"2","key":"10061_CR14","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.ajog.2005.01.022","volume":"193","author":"BD B\u00fcltmann","year":"2005","unstructured":"B\u00fcltmann BD, Klingel K, N\u00e4bauer M, Wallwiener D, Kandolf R (2005) High prevalence of viral genomes and inflammation in peripartum cardiomyopathy. Am J Obstet Gynecol 193(2):363\u2013365","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10061_CR15","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.ijcard.2006.04.090","volume":"118","author":"S Lamparter","year":"2007","unstructured":"Lamparter S, Pankuweit S, Maisch B (2007) Clinical and immunologic characteristics in peripartum cardiomyopathy. Int J Cardiol 118(1):14\u201320","journal-title":"Int J Cardiol"},{"issue":"11","key":"10061_CR16","doi-asserted-by":"publisher","first-page":"e19524","DOI":"10.1097\/MD.0000000000019524","volume":"99","author":"BT Tak","year":"2020","unstructured":"Tak BT, Cay S, Pamukcu HE et al (2020) Prognostic nutritional index as a novel marker for prediction of prognosis in patients with peripartum cardiomyopathy. Medicine (Baltimore) 99(11):e19524","journal-title":"Medicine (Baltimore)"},{"key":"10061_CR17","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1001\/archinte.1963.03620290117016","volume":"111","author":"JA Pierce","year":"1963","unstructured":"Pierce JA, Price BO, Joyce JW (1963) Familial occurrence of postpartal heart failure. Arch Intern Med 111:651\u2013655","journal-title":"Arch Intern Med"},{"issue":"20","key":"10061_CR18","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.1161\/CIRCULATIONAHA.109.931220","volume":"121","author":"A Morales","year":"2010","unstructured":"Morales A, Painter T, Li R et al (2010) Rare variant mutations in pregnancy-associated or peripartum cardiomyopathy. Circulation 121(20):2176\u20132182","journal-title":"Circulation"},{"issue":"32","key":"10061_CR19","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1093\/eurheartj\/ehu050","volume":"35","author":"KY van Spaendonck-Zwarts","year":"2014","unstructured":"van Spaendonck-Zwarts KY, Posafalvi A, van den Berg MP et al (2014) Titin gene mutations are common in families with both peripartum cardiomyopathy and dilated cardiomyopathy. Eur Heart J 35(32):2165\u20132173","journal-title":"Eur Heart J"},{"issue":"3","key":"10061_CR20","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1056\/NEJMoa1505517","volume":"374","author":"JS Ware","year":"2016","unstructured":"Ware JS, Li J, Mazaika E et al (2016) Shared Genetic Predisposition in Peripartum and Dilated Cardiomyopathies. N Engl J Med 374(3):233\u2013241","journal-title":"N Engl J Med"},{"issue":"7","key":"10061_CR21","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1056\/NEJMoa1110186","volume":"366","author":"DS Herman","year":"2012","unstructured":"Herman DS, Lam L, Taylor MR et al (2012) Truncations of titin causing dilated cardiomyopathy. N Engl J Med 366(7):619\u2013628","journal-title":"N Engl J Med"},{"issue":"5","key":"10061_CR22","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1046\/j.1365-2265.2002.01638.x","volume":"57","author":"V Toescu","year":"2002","unstructured":"Toescu V, Nuttall SL, Martin U, Kendall MJ, Dunne F (2002) Oxidative stress and normal pregnancy. Clin Endocrinol (Oxf) 57(5):609\u2013613","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"10061_CR23","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1038\/nrcardio.2014.37","volume":"11","author":"D Hilfiker-Kleiner","year":"2014","unstructured":"Hilfiker-Kleiner D, Sliwa K (2014) Pathophysiology and epidemiology of peripartum cardiomyopathy. Nat Rev Cardiol 11(6):364\u2013370","journal-title":"Nat Rev Cardiol"},{"key":"10061_CR24","doi-asserted-by":"publisher","first-page":"k5287","DOI":"10.1136\/bmj.k5287","volume":"364","author":"MC Honigberg","year":"2019","unstructured":"Honigberg MC, Givertz MM (2019) Peripartum cardiomyopathy. BMJ 364:k5287","journal-title":"BMJ"},{"issue":"3","key":"10061_CR25","doi-asserted-by":"publisher","first-page":"393","DOI":"10.3904\/kjim.2016.360","volume":"32","author":"MJ Kim","year":"2017","unstructured":"Kim MJ, Shin MS (2017) Practicalmanagementofperipartumcardiomyopathy. Korean J Intern Med 32(3):393\u2013403","journal-title":"Korean J Intern Med"},{"key":"10061_CR26","doi-asserted-by":"publisher","first-page":"476903","DOI":"10.1155\/2012\/476903","volume":"2012","author":"P Ballo","year":"2012","unstructured":"Ballo P, Betti I, Mangialavori G, Chiodi L, Rapisardi G, Zuppiroli A (2012) Peripartum cardiomyopathy presenting with predominant left ventricular diastolic dysfunction: efficacy of bromocriptine. Case Rep Med 2012:476903","journal-title":"Case Rep Med"},{"issue":"4","key":"10061_CR27","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1007\/s00395-013-0366-9","volume":"108","author":"A Haghikia","year":"2013","unstructured":"Haghikia A, Podewski E, Libhaber E et al (2013) Phenotyping and outcome on contemporary management in a German cohort of patients with peripartum cardiomyopathy. Basic Res Cardiol 108(4):366","journal-title":"Basic Res Cardiol"},{"issue":"3","key":"10061_CR28","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/S1388-9842(02)00008-9","volume":"4","author":"K Sliwa","year":"2002","unstructured":"Sliwa K, Skudicky D, Candy G, Bergemann A, Hopley M, Sareli P (2002) The addition of pentoxifylline to conventional therapy improves outcome in patients with peripartum cardiomyopathy. Eur J Heart Fail 4(3):305\u2013309","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"10061_CR29","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.cardfail.2017.10.012","volume":"24","author":"CF McTiernan","year":"2018","unstructured":"McTiernan CF, Morel P, Cooper LT et al (2018) Circulating T-cell subsets, monocytes, and natural killer cells in peripartum cardiomyopathy: results from the multicenter IPAC study. J Card Fail 24(1):33\u201342","journal-title":"J Card Fail"},{"issue":"2","key":"10061_CR30","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1097\/00000441-193708000-00005","volume":"194","author":"B Goulet","year":"1937","unstructured":"Goulet B, McMillan T, Bellet S (1937) Idiopathic myocardial degeneration associated with pregnancy and especially the puerpernium. Am J Med Sci 194(2):185\u2013199","journal-title":"Am J Med Sci"},{"issue":"1","key":"10061_CR31","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1161\/CIRCRESAHA.111.249037","volume":"110","author":"RJ Kara","year":"2012","unstructured":"Kara RJ, Bolli P, Karakikes I et al (2012) Fetal cells traffic to injured maternal myocardium and undergo cardiac differentiation. Circ Res 110(1):82\u201393","journal-title":"Circ Res"},{"issue":"6","key":"10061_CR32","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1161\/01.CIR.44.6.1053","volume":"44","author":"JG Demakis","year":"1971","unstructured":"Demakis JG, Rahimtoola SH, Sutton GC et al (1971) Naturalcourseofperipartumcardiomyopathy. Circulation 44(6):1053\u20131061","journal-title":"Circulation"},{"issue":"2","key":"10061_CR33","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.amjcard.2007.02.092","volume":"100","author":"SS Brar","year":"2007","unstructured":"Brar SS, Khan SS, Sandhu GK et al (2007) Incidence, mortality, and racial differences in peripartum cardiomyopathy. Am J Cardiol 100(2):302\u2013304","journal-title":"Am J Cardiol"},{"issue":"1","key":"10061_CR34","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/0167-5273(92)90108-F","volume":"36","author":"A C\u00e9nac","year":"1992","unstructured":"C\u00e9nac A, Simonoff M, Moretto P, Djibo A (1992) Alowplasmaseleniumisariskfactorforperipartum cardiomyopathy A comparative study in Sahelian Africa. Int J Cardiol 36(1):57\u201359","journal-title":"Int J Cardiol"},{"issue":"2\u20133","key":"10061_CR35","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/S0167-5273(02)00357-1","volume":"86","author":"JD Fett","year":"2002","unstructured":"Fett JD, Sundstrom BJ, Etta King M, Ansari AA (2002) Mother-daughter peripartum cardiomyopathy. Int J Cardiol 86(2\u20133):331\u2013332","journal-title":"Int J Cardiol"},{"issue":"4","key":"10061_CR36","doi-asserted-by":"publisher","first-page":"316","DOI":"10.7861\/clinmedicine.17-4-316","volume":"17","author":"PA Patel","year":"2017","unstructured":"Patel PA, Roy A, Javid R, Dalton JA (2017) A contemporary review of peripartum cardiomyopathy. Clin Med (Lond) 17(4):316\u2013321","journal-title":"Clin Med (Lond)"},{"issue":"2","key":"10061_CR37","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.jacc.2019.11.014","volume":"75","author":"MB Davis","year":"2020","unstructured":"Davis MB, Arany Z, McNamara DM, Goland S, Elkayam U (2020) Peripartum Cardiomyopathy: JACC state-of-the-art review. J Am Coll Cardiol 75(2):207\u2013221","journal-title":"J Am Coll Cardiol"},{"key":"10061_CR38","doi-asserted-by":"crossref","unstructured":"Sliwa K, Petrie MC, van der Meer P, et al. (2020) Clinical presentation, management, and 6-month outcomes in women with peripartum cardiomyopathy: an ESC EORP registry Eur Heart J 41(39):3787\u20133797 (In eng)","DOI":"10.1093\/eurheartj\/ehaa455"},{"issue":"1","key":"10061_CR39","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ijcard.2010.08.065","volume":"154","author":"JG Safirstein","year":"2012","unstructured":"Safirstein JG, Ro AS, Grandhi S, Wang L, Fett JD, Staniloae C (2012) Predictors of left ventricular recovery in a cohort of peripartum cardiomyopathy patients recruited via the internet. Int J Cardiol 154(1):27\u201331","journal-title":"Int J Cardiol"},{"key":"10061_CR40","unstructured":"Felker M, Mann D (2020)\u00a0A companion to Braunwald's heart disease. Heart failure\u00a0Vol Fourth Volume Elsevier inc."},{"key":"10061_CR41","doi-asserted-by":"crossref","unstructured":"Rodriguez Ziccardi M, Siddique MS (2001) Peripartum cardiomyopathy, StatPearls Publishing, 2020 Drugs AAoPCo.Transfer of drugs and other chemicals into human milk.Pediatrics 108:776\u201389","DOI":"10.1542\/peds.108.3.776"},{"key":"10061_CR42","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.jacc.2018.10.075","volume":"73","author":"DG Halpern","year":"2019","unstructured":"Halpern DG, Weinberg CR, Pinnelas R, Mehta-Lee S, Economy KE, Valente AM (2019) Use of medication for cardiovascular disease during pregnancy: JACC state-of-the-art review. J Am Coll Cardiol 73:457\u2013476","journal-title":"J Am Coll Cardiol"},{"issue":"24","key":"10061_CR43","doi-asserted-by":"publisher","first-page":"3147","DOI":"10.1093\/eurheartj\/ehr272","volume":"32","author":"V Regitz-Zagrosek","year":"2011","unstructured":"Regitz-Zagrosek V, Blomstrom Lundqvist C, Borghi C et al (2011) ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). Eur Heart J 32(24):3147\u20133197","journal-title":"Eur Heart J"},{"key":"10061_CR44","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.healun.2011.11.018","volume":"31","author":"K Rasmusson","year":"2012","unstructured":"Rasmusson K, Brunisholz K, Budge D et al (2012) Peripartum cardiomyopathy: post-transplant outcomes from the United Network for Organ Sharing Database. J Heart Lung Transplant 31:180\u2013186","journal-title":"J Heart Lung Transplant"},{"issue":"1","key":"10061_CR45","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.hfc.2018.08.004","volume":"15","author":"K Lindley","year":"2019","unstructured":"Lindley K, Verma V, Blauwet L (2019) Peripartum cardiomyopathy. Heart Failure Clinics 15(1):29\u201339","journal-title":"Heart Failure Clinics"},{"key":"10061_CR46","doi-asserted-by":"publisher","unstructured":"Sliwa K, Blauwet L, Tibazarwa K, et al (2010) Evaluation of bromocriptine in the treatment of acute severe peripartum cardiomyopathy: a proof-of-concept pilot study. Circulation 121(13):1465-73. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.109.901496","DOI":"10.1161\/CIRCULATIONAHA.109.901496"},{"key":"10061_CR47","unstructured":"Yameogo NV, Kagambega LJ, Seghda A, et al (2017) Bromocriptine in management of peripartum cardiomyopathy: A randomized study on 96 women in Burkina Faso. J Cardiol Clin Res 5:1098"},{"key":"10061_CR48","doi-asserted-by":"publisher","unstructured":"Hilfiker-Kleiner D, Haghikia A, Berliner D, et al (2017) Bromocriptine for the treatment of peripartum cardiomyopathy: a multicentre randomized study. Eur Heart J 38(35):2671-2679. https:\/\/doi.org\/10.1093\/eurheartj\/ehx355","DOI":"10.1093\/eurheartj\/ehx355"},{"key":"10061_CR49","doi-asserted-by":"crossref","unstructured":"Mason JW, O'Connell JB, Herskowitz A, et al. (1995) A clinical trial of immunosuppressive therapy for myocarditis The Myocarditis Treatment Trial Investigators N Engl J Med\u00a0333(5):269\u2013275","DOI":"10.1056\/NEJM199508033330501"},{"key":"10061_CR50","doi-asserted-by":"crossref","unstructured":"Drugs AAoPCo (2001) Transfer of drugs and other chemicals into human milk. Pediatrics 108(3):776\u2013789","DOI":"10.1542\/peds.108.3.776"},{"issue":"8","key":"10061_CR51","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.jacc.2015.06.1309","volume":"66","author":"DM McNamara","year":"2015","unstructured":"McNamara DM, Elkayam U, Alharethi R et al (2015) Clinical outcomes for peripartum cardiomyopathy in North America: results of the IPAC Study (Investigations of Pregnancy- Associated Cardiomyopathy). J Am Coll Cardiol 66(8):905\u2013914","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10061_CR52","first-page":"415.e411","volume":"199","author":"M Habli","year":"2008","unstructured":"Habli M, O\u2019Brien T, Nowack E, Khoury S, Barton JR, Sibai B (2008) Peripartum cardiomyopathy: prognostic factors for long-term maternal outcome. Am J Obstet Gynecol 199(4):415.e411-415","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"10061_CR53","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s00404-009-1170-5","volume":"281","author":"M Moioli","year":"2010","unstructured":"Moioli M, Valenzano Menada M, Bentivoglio G, Ferrero S (2010) Peripartum cardiomyopathy. Arch Gynecol Obstet 281(2):183\u2013188","journal-title":"Arch Gynecol Obstet"},{"key":"10061_CR54","doi-asserted-by":"crossref","unstructured":"Elkayam U, Sch\u00e4fer A, Chieffo A, et al. (2019) Use of Impella heart pump for management of women with peripartum cardiogenic shock Clin Cardiol 2019;42(10):974\u2013981 (In eng)\u00a0https:\/\/doi.org\/10.1002\/clc.23249","DOI":"10.1002\/clc.23249"},{"key":"10061_CR55","doi-asserted-by":"crossref","unstructured":"Sieweke JT, Pfeffer TJ, Berliner D, et al. (2020) Cardiogenic shock complicating peripartum cardiomyopathy: importance of early left ventricular unloading and bromocriptine therapy Eur Heart J Acute Cardiovasc Care 9(2):173\u2013182 (In eng)\u00a0https:\/\/doi.org\/10.1177\/2048872618777876","DOI":"10.1177\/2048872618777876"},{"key":"10061_CR56","doi-asserted-by":"crossref","unstructured":"Sliwa K, Petrie MC, Hilfiker-Kleiner D, et al. (2018) Long-term prognosis, subsequent pregnancy, contraception and overall management of peripartum cardiomyopathy: practical guidance paper from the Heart Failure Association of the European Society of Cardiology Study Group on Peripartum Cardiomyopathy Eur J Heart Fail 20(6):951\u2013962 (In eng) https:\/\/doi.org\/10.1002\/ejhf.1178","DOI":"10.1002\/ejhf.1178"}],"container-title":["Heart Failure Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-020-10061-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10741-020-10061-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-020-10061-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,31]],"date-time":"2022-12-31T13:46:36Z","timestamp":1672494396000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10741-020-10061-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,17]]},"references-count":56,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["10061"],"URL":"https:\/\/doi.org\/10.1007\/s10741-020-10061-x","relation":{},"ISSN":["1382-4147","1573-7322"],"issn-type":[{"value":"1382-4147","type":"print"},{"value":"1573-7322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,17]]},"assertion":[{"value":"30 November 2020","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}